Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?

BackgroundThe use of anticoagulants is an established strategy to prevent stroke, embolism, and cardiovascular mortality in patients with atrial fibrillation (AF), but its role in the prevention of incident diabetes is unclear. We aimed to investigate this question by using participant data from coh...

Full description

Bibliographic Details
Main Authors: Xuyang Liu, Shenghui Feng, Zhuohui Chen, Yue Zhou, Kang Yin, Zhengbiao Xue, Wengen Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atrial fibrillation
non-vitamin K antagonist oral anticoagulants
diabetes mellitus
warfarin
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.874795/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.874795/full

Similar Items